Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2026-03-06 @ 12:34 AM
Study NCT ID:
NCT02961556
Status:
COMPLETED
Last Update Posted:
2017-10-24
First Post:
2016-11-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
General Clinical Study of AJG555 in Pediatric Patients With Chronic Constipation
Sponsor:
EA Pharma Co., Ltd.
Organization:
Study Overview
Official Title:
General Clinical Study of AJG555 in Pediatric Patients With Chronic Constipation
Status:
COMPLETED
Status Verified Date:
2017-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This baseline-controlled, open-label, multicenter study evaluates the efficacy and safety of AJG555 orally administered for 2 weeks in pediatric participants with chronic constipation. The safety and efficacy of 12 weeks of administration will also be evaluated.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: